DE SANTIS, FEDERICO
 Distribuzione geografica
Continente #
NA - Nord America 1.110
AS - Asia 689
EU - Europa 658
SA - Sud America 178
AF - Africa 11
OC - Oceania 1
Totale 2.647
Nazione #
US - Stati Uniti d'America 1.063
SG - Singapore 324
RU - Federazione Russa 229
BR - Brasile 148
IT - Italia 145
VN - Vietnam 114
CN - Cina 89
DE - Germania 72
HK - Hong Kong 69
FI - Finlandia 41
FR - Francia 36
GB - Regno Unito 33
CA - Canada 21
NL - Olanda 20
IN - India 18
MX - Messico 18
AT - Austria 16
AR - Argentina 14
ES - Italia 14
BD - Bangladesh 13
IE - Irlanda 11
PL - Polonia 11
JP - Giappone 8
IQ - Iraq 7
TR - Turchia 7
UZ - Uzbekistan 7
SA - Arabia Saudita 6
CZ - Repubblica Ceca 5
PK - Pakistan 5
SE - Svezia 5
VE - Venezuela 5
CO - Colombia 4
KZ - Kazakistan 4
UA - Ucraina 4
ZA - Sudafrica 4
AE - Emirati Arabi Uniti 3
EC - Ecuador 3
KE - Kenya 3
RS - Serbia 3
BE - Belgio 2
CL - Cile 2
EG - Egitto 2
GT - Guatemala 2
HU - Ungheria 2
ID - Indonesia 2
LT - Lituania 2
MY - Malesia 2
PA - Panama 2
PH - Filippine 2
AU - Australia 1
BB - Barbados 1
BG - Bulgaria 1
CH - Svizzera 1
CY - Cipro 1
DK - Danimarca 1
DZ - Algeria 1
ET - Etiopia 1
GD - Grenada 1
GE - Georgia 1
GR - Grecia 1
HN - Honduras 1
HR - Croazia 1
IL - Israele 1
JM - Giamaica 1
JO - Giordania 1
LK - Sri Lanka 1
LV - Lettonia 1
MM - Myanmar 1
MN - Mongolia 1
PE - Perù 1
PS - Palestinian Territory 1
PY - Paraguay 1
RO - Romania 1
TH - Thailandia 1
Totale 2.647
Città #
Dallas 438
Singapore 211
San Jose 147
Ashburn 83
Hong Kong 64
Santa Clara 43
Ho Chi Minh City 41
The Dalles 35
Munich 33
Hanoi 30
Verona 28
Los Angeles 24
Moscow 24
New York 24
Boardman 23
Council Bluffs 23
Beijing 22
Lauterbourg 21
Lappeenranta 19
São Paulo 18
Benevento 15
Hefei 12
Helsinki 12
Montreal 12
Dublin 11
Mexico City 11
Poplar 11
Turku 10
Warsaw 10
Brooklyn 9
Falkenstein 9
Da Nang 8
Düsseldorf 8
Orem 8
Rome 8
Tokyo 8
Denver 7
Florence 7
Kitzingen 7
London 7
L’Aquila 7
Vienna 7
Atlanta 6
Boston 6
Curitiba 6
Frankfurt am Main 6
Shanghai 6
Tashkent 6
Toronto 6
Ankara 5
Chennai 5
Jinan 5
Portsmouth 5
Seattle 5
Amsterdam 4
Campinas 4
Changsha 4
Chicago 4
Haiphong 4
Houston 4
Milan 4
Mumbai 4
Phoenix 4
Querétaro 4
Rio de Janeiro 4
Stockholm 4
Thái Nguyên 4
West Jordan 4
Annapolis 3
Bologna 3
Catania 3
Charlotte 3
Fort Worth 3
Johannesburg 3
Lahore 3
Manchester 3
Nairobi 3
Olomouc 3
Raleigh 3
Santo André 3
Spoltore 3
St Louis 3
Teramo 3
Thái Bình 3
Agropoli 2
Aparecida 2
Astana 2
Bauru 2
Belgrade 2
Brno 2
Brussels 2
Bắc Ninh 2
Can Tho 2
Caserta 2
Concord 2
Franca 2
Genoa 2
Goiânia 2
Guangzhou 2
Hortolândia 2
Totale 1.758
Nome #
Characteristics and causes of recurrent ischemic events in minor ischemic stroke and TIA in the READAPT study 347
Real‐World Dual Antiplatelet Therapy Use Exceeds Randomized Trials Boundaries With Possible Safety Issues in Patients With Large Artery Atherosclerosis—Insights From the READAPT Study 115
Real-world outcomes following dual antiplatelet therapy in mild-to-moderate ischemic stroke with anterior versus posterior circulation infarct: a READAPT study propensity matched analysis 102
Divergence Between Clinical Trial Evidence and Actual Practice in Use of Dual Antiplatelet Therapy After Transient Ischemic Attack and Minor Stroke 97
Do antithrombotic drugs have a role in migraine prevention? A systematic review 96
A REAl-life study on short-term Dual Antiplatelet treatment in Patients with ischemic stroke or Transient ischemic attack (READAPT) 94
Effectiveness of transcranial direct current stimulation and monoclonal antibodies acting on the CGRP as a combined treatment for migraine (TACTIC): Results of a randomized controlled trial 94
Effectiveness and tolerability of atogepant in the prevention of migraine: A real life, prospective, multicentric study (the STAR study) 93
Epidemiology and treatment of atraumatic subarachnoid hemorrhage over 10 years in a population-based registry 92
Impact of duration of chronic migraine on long‐term effectiveness of monoclonal antibodies targeting the calcitonin gene‐related peptide pathway—A real‐world study 91
Association of anti‐calcitonin gene‐related peptide with other monoclonal antibodies for different diseases: A multicenter, prospective, cohort study 91
Real-world comparison of dual versus single antiplatelet treatment in patients with non-cardioembolic mild-to-moderate ischemic stroke: a propensity matched analysis 90
Primary headache epidemiology in children and adolescents: a systematic review and meta-analysis 90
Defining short-term outcomes of minor ischemic stroke due to small artery occlusion in the era of dual antiplatelet treatment: A READAPT study sub-analysis 88
Sex Differences in the Epidemiology of Intracerebral Hemorrhage Over 10 Years in a Population‐Based Stroke Registry 80
Combining Intravenous Thrombolysis and Dual Antiplatelet Treatment in Patients With Minor Ischemic Stroke: A Propensity Matched Analysis of the READAPT Study Cohort 76
Incidence and prognosis of first-ever intracerebral hemorrhage on antiplatelet therapy over 10 years in a population-based stroke registry 76
Effectiveness and safety of dual antiplatelet therapy in patients with minor ischemic stroke or transient ischemic attack and cancer: A secondary analysis of the READAPT study 76
Admission systolic blood pressure and short-term outcomes after dual antiplatelet therapy in patients with minor ischemic stroke or transient ischemic attack 75
Beyond RCTs: Short-term dual antiplatelet therapy in secondary prevention of ischemic stroke and transient ischemic attack 74
Exploring Sex Differences in Outcomes of Dual Antiplatelet Therapy for Patients With Noncardioembolic Mild-to-Moderate Ischemic Stroke or High-Risk Transient Ischemic Attack: A Propensity-Matched Analysis of the READAPT Study Cohort 72
Prevention and treatment of ischaemic and haemorrhagic stroke in people with diabetes mellitus: a focus on glucose control and comorbidities 69
Risk of stroke with different levels of leisure-time physical activity: a systematic review and meta-analysis of prospective cohort studies 63
Transient brain ischemic symptoms and the presence of ischemic lesions at neuroimaging: Results from the READAPT study 62
Predictors of atrial fibrillation detection in embolic stroke of undetermined source patients with implantable loop recorder 62
Epidemiology and outcomes of intracerebral hemorrhage associated with oral anticoagulation over 10 years in a population-based stroke registry 55
A call for academic pragmatic clinical trials to address open questions in migraine prevention 54
Migraine with aura, thrombophilia, and the debate on white matter hyperintensities 46
Clinical characteristics and outcomes of ischemic stroke despite appropriate oral anticoagulation for atrial fibrillation: A systematic review and meta-analysis of real-world studies 34
Sex differences in the clinical features of 2,841 patients with migraine: a post-hoc, multicenter, cross-sectional study 31
Acute Treatment of Disabling and Nondisabling Minor Ischemic Stroke: Expert Guidance for Clinicians 28
The potential role of sleep quality in the relationship between glymphatic function and migraine frequency: Insights from a cross-sectional study 23
Atrial fibrillation detection after Embolic Stroke of Undetermined Source: development and validation of the CATCH-AF score 22
Impact of cancer on outcomes following breakthrough ischaemic stroke on oral anticoagulants for atrial fibrillation: insights from the ASPERA-R study 21
null 7
Totale 2.686
Categoria #
all - tutte 8.259
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.259


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/202318 0 0 0 0 0 0 0 1 10 1 3 3
2023/202469 2 2 5 5 3 8 0 4 2 13 3 22
2024/2025665 20 5 32 35 59 48 89 50 137 48 77 65
2025/20261.934 74 405 147 272 203 105 211 96 166 255 0 0
Totale 2.686